ArticleRenal failure2026
Risk stratification for in-hospital mortality in sepsis-associated acute kidney injury patients receiving continuous renal replacement therapy: an interpretable, externally validated machine learning study.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with sepsis-associated acute kidney injury (SA-AKI) requiring continuous renal replacement therapy (CRRT) have a high risk of in-hospital mortality, and early risk stratification may support timely clinical decision-making and efficient resource allocation. In this retrospective study, we developed and validated a prognostic model for SA-AKI patients receiving CRRT using data from the Medical Information Mart for Intensive Care IV (MIMIC-IV version 3.1 United States, 2008-2022) and the eICU Collaborative Research Database (eICU-CRD United States, 2014-2015), with external validation in an independent cohort from the intensive care unit of the Second Affiliated Hospital of Anhui Medical University (AYEFY-ICU China, 2021-2024). Candidate variables were selected using the least absolute shrinkage and selection operator (LASSO) and Boruta algorithms, and eight machine learning models were constructed and compared. Model interpretability was assessed using SHapley Additive exPlanations (SHAP). A total of 1,217 patients from the MIMIC-IV and eICU-CRD databases and 332 patients from the AYEFY-ICU cohort were included, and ten predictors were ultimately identified. Among the evaluated models, the gradient boosting machine (GBM) showed strong performance, with AUCs of 0.890, 0.756, and 0.752 in the training, internal validation, and external validation cohorts, respectively. In the external cohort, its performance was comparable to XGBoost and LightGBM without significant differences, with overlapping confidence intervals, while exceeding conventional scores (SOFA, SAPS II). SHAP analysis identified urine output, serum creatinine, and age as key predictors. This multicenter-derived GBM model may support early risk stratification and clinical decision-making in SA-AKI patients receiving CRRT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.